How long do you take Jakafi?
How long do you take Jakafi?
Jakafi is a long-term treatment. Your Healthcare Professional may allow up to 6 months to see if Jakafi is working for you. If you do not see an improvement after 6 months of treatment, your Healthcare Professional may have you stop taking Jakafi.
What is Jakafi prescribed for?
This medication is used to treat certain bone marrow disorders (myelofibrosis, polycythemia vera). It works by blocking your body from producing substances called growth factors. Growth factors cause cells to grow and divide, and cause the blood cell and spleen problems found in these disorders.
What are the side effects of the drug Jakafi?
The most common side effects of Jakafi include: for certain types of myelofibrosis (MF) and polycythemia vera (PV) – low platelet or red blood cell counts, bruising, dizziness, headache, and diarrhea; for acute GVHD – low platelet counts, low red or white blood cell counts, infections, and swelling; and for chronic …
What is the monthly cost of Jakafi?
The cost for Jakafi oral tablet 5 mg is around $15,798 for a supply of 60 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans….Oral Tablet.
Quantity | Per unit | Price |
---|---|---|
60 | $263.30 | $15,797.91 |
Does jakafi make tired?
low blood cell counts–fever, chills, tiredness, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed or short of breath; or. signs of tuberculosis: fever, cough, night sweats, loss of appetite, weight loss, and feeling very tired.
Does jakafi cause memory problems?
Many suspect that the virus becomes active after drugs suppress the immune system. In many cases, the infection results in death. Symptoms of PML could include changes in mood, unusual behavior, confusion, memory loss, weakness or loss of strength on one side of the body, or problems with vision, speech or walking.
Does Jakafi cause memory loss?
In many cases, the infection results in death. Symptoms of PML could include changes in mood, unusual behavior, confusion, memory loss, weakness or loss of strength on one side of the body, or problems with vision, speech or walking.
Does Jakafi cause mood swings?
They may include changes in mood or usual behavior, confusion, thinking problems, loss of memory, changes in vision, speech, or walking, and decreased strength or weakness on one side of the body. Hepatitis B: People with chronic Hepatitis B will be monitored closely during treatment, typically through blood tests.
Is jakafi a chemo pill?
Jakafi is not chemotherapy. It is a targeted treatment that works to help keep the production of blood cells under control. Discover what may be possible with Jakafi for the treatment of polycythemia vera in patients who did not benefit from HU.
How do you get Jakafi?
HOW TO ENROLL IN IncyteCARES FOR JAKAFI
- Call IncyteCARES to get started at 1-855-452-5234.
- Call IncyteCARES to get started at 1-855-452-5234.
- Ask your prescribing Healthcare Professional to enroll you.
How often do you take Jakafi?
Take Jakafi exactly as instructed by your Healthcare Professional. For most patients, the starting dose of Jakafi is one tablet taken twice a day by mouth. In certain cases, a Healthcare Professional may start a patient at a lower dose or temporarily reduce the dose of Jakafi to once a day.
Is Jakafi a type of chemo drug?
Is Jakafi a chemo drug?
Jakafi is the first and only medicine approved by the Food and Drug Administration (FDA) for the treatment of these patients. Jakafi is not chemotherapy. It is a targeted treatment that works to help keep the production of blood cells under control.
Jakafi is used to treat myelofibrosis or polycythemia vera, which are bone marrow disorders that that affect your body’s ability to produce blood cells. Jakafi is also used to treat acute graft versus host disease (GVHD) in adults and children 12 years of age and older who have taken corticosteroids and they did not work well enough.
Does Jakafi cure myelofibrosis?
Jakafi can relieve the symptoms of myelofibrosis but it cannot provide a complete cure. Jakafi is the only drug that the FDA has approved for the treatment of myelofibrosis (MF). It is also known as ruxolitinib.
What does Jakafi treat?
It is used to treat myelofibrosis.